Apoptosis and metastases – what happens in cancer cells?
Apoptosis – programmed cell death
Apoptosis refers to natural, controlled cell death. Healthy cells have built-in mechanisms that specifically break down damaged or dysfunctional cells. This process is essential for maintaining the balance between cell regeneration and cell death in the body.
In cancer cells, this mechanism is often disrupted or blocked. Tumor cells evade apoptosis, continue to divide uncontrollably, and survive even when they should actually be eliminated. This ability is a key characteristic of cancer.

Metastases – Spread of tumor cells
Metastases occur when cancer cells detach from the original tumor, spread through the blood or lymphatic system, and settle in other organs. There, they can form new tumor sites, often independently of the original tumor.
Metastasis is a complex process that includes, among other things:
-
Loss of cell adhesion in the primary tumor
-
Penetration into blood or lymph vessels
-
Survival in the bloodstream
-
Settlement and growth in distant organs
Metastatic tumor cells in particular often have mechanisms to evade apoptosis and escape immune surveillance.
​
Therapeutic approaches: promoting apoptosis and controlling metastasis
Modern cancer therapies increasingly aim to influence several biological mechanisms simultaneously. The focus is on the following strategies, among others:
-
Reactivation of apoptotic signaling pathways to make cancer cells susceptible to programmed cell death again
-
Inhibition of growth and survival signals in tumor cells
-
Supporting the immune system so that degenerated cells can be better recognized and eliminated
-
Reducing the ability to metastasize, e.g., by influencing the tumor microenvironment
Combination therapies – an integrative approach
Since cancer is a complex process, combination therapies are becoming increasingly important. The aim is to combine different mechanisms of action in a meaningful way and tailor them to the individual patient.
Possible combinable therapeutic approaches include:
-
Classic oncological therapies (e.g., chemotherapy, hormone therapy, radiation)
-
Immunological procedures, such as dendritic cell therapy for targeted activation of the immune response
-
Accompanying immune-building and supportive measures that stabilize the immune system
-
Metabolic and cell biological approaches that target the growth and survival mechanisms of tumor cells
-
The combination is not based on a fixed scheme, but is oriented toward:
-
Tumor type and stage
-
The presence of metastases
-
The patient's immune status
-
Previous therapies and tolerability
The goal of modern therapy concepts
The overarching goal of integrative combination therapies is to
-
make cancer cells vulnerable again,
-
support the body's own immune defenses,
-
and limit the spread of tumor cells as much as possible.
The focus is not only on tumor control, but also on the quality of life and individual situation of those affected.
​
Important note
The approaches mentioned do not constitute a promise of cure and do not replace guideline-based oncological treatment. Whether and which combination therapies are appropriate must always be assessed individually and by a physician.
